DOI: 10.1001/jamainternmed.2026.4520 ISSN: 2168-6106

Policy and Design Considerations for Most-Favored-Nation Drug Pricing

Matthew Vogel, Olivier J. Wouters

This Viewpoint discusses most-favored-nation drug pricing and how to strengthen this type of drug pricing in Medicare.